A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease

Fujita Health University Hospital, Aichi

University of Fukui Hospital, Fukui

Kyushu University Hospital, Fukuoka

Hiroshima University Hospital, Hiroshima

Hokkaido University Hospital, Hokkaido

Kobe City Medical Center General Hospital, Hyōgo

Tokai University Hospital, Kanagawa

National Hospital Organization Kumamoto Medical Center, Kumamoto

Tohoku University Hospital, Miyagi

Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya

Okayama University Hospital, Okayama

Osaka Prefectural Hospital Organization Osaka International Cancer Institute, Osaka

Osaka Metropolitan University Hospital, Osaka

Saitama Prefectural Children'S Medical Center, Saitama-shi, Saitama,

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo

National Center For Child Health and Development, Tokyo